Pathogen-Reduction for Platelet Concentrates

被引:0
|
作者
Weber, C. F. [1 ]
Heim, M. U. [2 ]
机构
[1] Goethe Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain Therapy, D-60590 Frankfurt, Germany
[2] Otto von Guericke Univ Hosp, Inst Transfus Med & Immunohematol, Magdeburg, Germany
关键词
FUNCTIONAL-CHARACTERISTICS; THERAPEUTIC-EFFICACY; APHERESIS PLATELETS; TREATED PLATELETS; SPRINT TRIAL; INACTIVATION; SAFETY; LIGHT; ULTRAVIOLET; TECHNOLOGY;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:293 / 295
页数:3
相关论文
共 50 条
  • [1] Pathogen-reduction methods: advantages and limits
    Klein, H. G.
    Bryant, B. J.
    ISBT SCIENCE SERIES, VOL 4, NO 1, STATE OF THE ART PRESENTATIONS, 2009, 4 (01): : 154 - +
  • [2] Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction
    Tauszig, Marie E.
    Picker, Susanne M.
    Gathof, Birgit S.
    TRANSFUSION AND APHERESIS SCIENCE, 2012, 46 (01) : 33 - 37
  • [3] Pathogen inactivation/reduction of platelet concentrates: turning theory into practice
    Gathof, B. S.
    Tauszig, M. E.
    Picker, S. M.
    STATE OF THE ART PRESENTATIONS, 2010, 5 (01): : 114 - 119
  • [4] Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction
    Kerkhoffs, Jean-Louis H.
    van Putten, Wim L. J.
    Novotny, Viera M. J.
    Boekhorst, Peter A. W. Te
    Schipperus, Martin R.
    Zwaginga, Jaap Jan
    van Pampus, Lizzy C. M.
    de Greef, Georgine E.
    Luten, Marleen
    Huijgens, Peter C.
    Brand, Anneke
    van Rhenen, Dick J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (02) : 209 - 217
  • [5] UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma
    Seltsam, Axel
    Mueller, Thomas H.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2011, 38 (01) : 43 - 54
  • [6] Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies
    Rebulla, Paolo
    Vaglio, Stefania
    Beccaria, Francesco
    Bonfichi, Maurizio
    Carella, Angelo
    Chiurazzi, Federico
    Coluzzi, Serelina
    Cortelezzi, Agostino
    Gandini, Giorgio
    Girelli, Gabriella
    Graf, Maria
    Isernia, Paola
    Marano, Giuseppe
    Marconi, Maurizio
    Montemezzi, Rachele
    Olivero, Barbara
    Rinaldi, Marianna
    Salvaneschi, Laura
    Scarpato, Nicola
    Strada, Paolo
    Milani, Silvano
    Grazzini, Giuliano
    TRANSFUSION, 2017, 57 (05) : 1171 - 1183
  • [7] Evaluation of bacterial safety approaches of platelet blood concentrates: bacterial screening and pathogen reduction
    Rezvany, Mohammad Reza
    Hasan-Abad, Amin Moradi
    Sobhani-Nasab, Ali
    Esmaili, Mohammad Ali
    FRONTIERS IN MEDICINE, 2024, 11
  • [8] Pathogen inactivation of platelet concentrates
    Reesink, H. W.
    Panzer, S.
    McQuilten, Z. K.
    Wood, E. M.
    Marks, C.
    Wendel, S.
    Trigo, F.
    Biagini, S.
    Olyntho, S.
    Devine, D. V.
    Mumford, I.
    Cazenave, J. -P.
    Rasongles, P.
    Garraud, O.
    Richard, P.
    Schooneman, F.
    Vezon, G.
    Al Radwan, R.
    Brand, A.
    Hervig, T.
    Castro, E.
    Lozano, M.
    Navarro, L.
    Puig, L.
    Almazan, C.
    MacLennan, S.
    Cardigan, R.
    Franklin, I. M.
    Prowse, C.
    VOX SANGUINIS, 2010, 99 (01) : 85 - 95
  • [9] The effects of pathogen reduction technology on apheresis platelet concentrates stored in Pas
    Tsalas, Stavros
    Tsantes, Andreas G.
    Petrou, Eleni
    Mellou, Sofia
    Sokou, Rozeta
    Loukopoulou, Electra
    Kriebardis, Anastasios G. .
    Fortis, Sotirios P.
    Papadopoulos, Dimitrios V.
    Vaiopoulos, Aristeidis G.
    Kokoris, Styliani
    Tsantes, Argirios E.
    BLOOD TRANSFUSION, 2024, 22 (05)
  • [10] Pathogen reduction of double-dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects
    Rosskopf, Konrad
    Helmberg, Wolfgang
    Schlenke, Peter
    TRANSFUSION, 2020, 60 (09) : 2058 - 2066